The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
FAonline INC is voluntarily recalling all lots within expiry of the ForeverMen capsules to the consumer level. FDA analysis founds these products to ...
read more
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of ...
read more
Amylyx Pharmaceuticals, Inc. announced the company has started a process with the U.S. FDA and Health Canada to voluntarily discontinue the marketing ...
read more
Wednesday, April 10, 2024
Ginkgo Bioworks announced the expansion of its strategic partnership with Novo Nordisk under a framework agreement that initially is contemplated to ...
read more
Wednesday, April 10, 2024
Essential Pharma, a specialty pharma group has completed the acquisition of the entire issued share capital of Renaissance Pharma Ltd. Renaissance ...
read more
Wednesday, April 10, 2024
Ascend Advanced Therapies has acquired the CMC team and site in Alachua, Florida from Beacon Therapeutics. The transaction brings an operational good ...
read more
Wednesday, April 10, 2024
Lisata Therapeutics, Inc. announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation (“ODD”) to LSTA1, the Company’s ...
read more
Wednesday, April 10, 2024
Charles River Laboratories International, Inc. announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration with ...
read more
Wednesday, April 10, 2024
BrainStorm Cell Therapeutics Inc. , a developer of adult stem cell therapeutics for neurodegenerative diseases, announced that it received written ...
read more
Charles River Laboratories International, Inc. announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing ...
read more
TME Pharma N.V. announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for NOX-A12 (olaptesed pegol), TME Pharma'...
read more
ARCA biopharma, Inc. and Oruka Therapeutics announced that they have entered into a definitive agreement to combine the companies in an all-stock ...
read more
Morris & Dickson announced it is the first U.S. distributor of Bavarian Nordic’s newly launched mpox vaccine, JYNNEOS®. As the only FDA-approved mpox ...
read more
The FDA approved Zevtera (ceftobiprole medocaril sodium for injection) for the treatment of adults with Staphylococcus aureus bloodstream infections (...
read more
Merck announced the initiation of a Phase 3 clinical trial evaluating MK-1084, an investigational oral selective KRAS G12C inhibitor, in combination ...
read more